Cancer Institute A national cancer institute
designated cancer center
Profile http://med.stanford.edu/profiles/cancer/researcher/Sally_Glaser/
Email this profile
Portrait View Larger

Sally Glaser

Key Documents

Contact Information

  • Academic Offices
    Personal Information
    Email
    Alternate Contact
    Tel Work 510-608-5042

Bio

Academic Appointments

Administrative Appointments

  • Chief Executive Officer, Cancer Prevention Institute of California (formerly Northern California Cancer Center) (2009 - 2013)
  • Interim Executive Director, Nothern California Cancer Center (2008 - 2009)
  • Director, Greater Bay Area Cancer Registry, Cancer Prevention Institute of California (Northern California Cancer Center) (2005 - present)
  • Director, Surveillance Research, Northern California Cancer Center (2000 - 2006)

Professional Education

Ph.D.: UC Berkeley, Epidemiology (1984)
M.S.: UC Berkeley, Epidemiology (1978)
A.B.: Harvard College, Social Relations (1972)

Research & Scholarship

Current Research and Scholarly Interests

Research

Hodgkin lymphoma: Dr. Glaser has conducted numerous studies in the epidemiology of Hodgkin lymphoma, including descriptive analyses and population-based studies in women and to characterize the epidemiologic features of Epstein-Barr virus (EBV)-associated Hodgkin lymphoma. With colleagues Dr. Richard Ambinder and Dr. Margaret Gulley, Dr. Glaser evaluated the reliability of EBV detection assays, generating interpretation guidelines to minimize this variation. Dr. Glaser’s current research interests in Hodgkin lymphoma involve genetic determinants of risk and their interaction with environmental factors.

Breast cancer: Dr. Glaser has been involved in numerous studies of incidence and survival patterns of breast cancer. Her analytic studies have focused on immune function modulators.

Surveillance Research: Within the Greater Bay Area Cancer Registry, part of the NCI's SEER program, Dr. Glaser built a research program dedicated to the insightful use of population-based cancer registry data to inform understanding of site-specific cancer incidence and survival patterns in various population subgroups, particularly those defined by race/ethnicity and socioeconomic status. This program has had particular interest in breast, colon and prostate cancers, and in lymphomas, as well in examining racial/ethnic and birthplace disparities in cancer incidence and survival.

Administration

Registry leadership: Dr. Glaser has been the Director of the Greater Bay Area Cancer Registry since 2005. She and her registry team are committed to excellence in registry function and to preparing for changes facing cancer registration, including increasing electronic data transmission and expanding data content to include more information on biomarkers, comorbidities and intermediate endpoints such as recurrence.

Dr. Glaser served as the leader of the Cancer Prevention Institute of California from 2008 through 2013.

Publications

Publications

Publication tag cloud

Publication Topics

View All 95

Stanford Medicine Resources:

Footer Links: